Stockscreener 앱 받기
0.00
0.00%
0.00
Vitro Biopharma, Inc. 주식(VTRO)의 최신 뉴스
Vitro Biopharma Receives ISO 13485 Certification Supporting its Stem Cell Medical Tourism Initiative - ACCESS Newswire
Vitro Biopharma Retains Leading Health Care Executive as Acting Director of Regulatory Affairs & Director - ACCESS Newswire
10 cultured meat companies driving sustainable food in 2025 - Labiotech.eu
Vitro Biopharma's AlloRx Stem Cell TherapyFeatured in New York Times Article on Health Secretary Kennedy's, Vision for Expanding Access to Regenerative Medicine - ACCESS Newswire
Vitro Biopharma's AlloRx Stem Cell Therapy Featured in New York Times Article on Health Secretary Kennedy's Vision for Expanding Access to Regenerative Medicine - ACCESS Newswire
GC Genome plans $30M IPO to diversify genomic products, suppliers - BioWorld MedTech
Vitro Biopharma, Inc. announced a financing transaction - marketscreener.com
Vitro Biopharma Receives FDA Authorization to Conduct a Clinical Trial Using AlloRx Stem Cells(R) to Treat COVID-19 - ACCESS Newswire
Vitro Biopharma’s CEO Elaborates on Merger-Driven Growth Acceleration in an Interview with the Wall Street Analyst - ACCESS Newswire
Be Biopharma to Present at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting - CRISPR Medicine News
Press Release Distribution & PR Platform - ACCESS Newswire
Contrasting Vitro Diagnostics (OTCMKTS:VODG) and Vaxcyte (NASDAQ:PCVX) - Defense World
Emulate Applauds FDA’s Roadmap to Reduce Animal Testing and Embrace Organ-Chip Technologies - BioSpace
Vitro Diagnostics (OTCMKTS:VODG) & Fennec Pharmaceuticals (NASDAQ:FENC) Head to Head Survey - Defense World
Vitro Biopharma Announces Early 2016 Results: Increased Revenue and Expansion Activities to Fuel Growth - ACCESS Newswire
Dealmaking Quarterly Statistics, Q2 2022 - insights.citeline.com
These 10 biotech companies are changing how we discover new drugs and treat complex diseases - Fast Company
COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product - Yahoo Finance
Vitro Biopharma Products Advance Pancreatic Cancer Research - ACCESS Newswire
Vitro Biopharma Revenues Increase in Early 2014: Plans Trials of Endogenous Stem Cell Activation for Therapeutic Benefit - ACCESS Newswire
Best Biotech Stocks to Buy in 2025 - The Motley Fool
Vitro Biopharma Announces Advances in Stem Cell Therapy without Transplants - ACCESS Newswire
What Stem Cell Clinics Do You Trust? - BioInformant
How a virtual company leveraged data to accelerate drug development for neurodegenerative diseases - Labiotech.eu
Dealmaking Quarterly Statistics, Q4 2024 - insights.citeline.com
Vitro Diagnostics (OTCMKTS:VODG) vs. HilleVax (NASDAQ:HLVX) Financial Review - Defense World
Reviewing Cyclo Therapeutics (NASDAQ:CYTH) and Vitro Diagnostics (OTCMKTS:VODG) - Defense World
Financing Quarterly Statistics, Q4 2024 - Citeline
Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner - Business Wire
Vitro Biopharma Inc. January 31st 2021, 1st Quarter ended Financial Results of Operations and Shareholder Letter - ACCESS Newswire
Achieving success in biopharma with recombinant antibody technology - News-Medical
Onconetix Resolves Nasdaq Compliance Issue After Late Q3 Filing - Stock Titan
The In Vitro Activity of Rezafungin Against Uncommon Species of CandidaWinkler2024Mycoses - Wiley Online Library
In Vitro Diagnostics (IVD) Market Size to Surpass USD 157.56 Billion by 2034 - BioSpace
Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations - Business Wire
Vitro Biopharma, Inc. announced that it has received $1 million in funding - MarketScreener
Top 5 In-Vitro Diagnostics [IVD] Companies, Worldwide by 2024 - Fortune Business Insights
Fapon Biotech Delivers Antigen Diagnostic Solutions to Help Control Monkeypox Outbreak in Africa - PR Newswire
Non-Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease (PLpro): In Vitro and In Vivo Antiviral Activity - ACS Publications
(PDF) Comprehensive Review on Drug Discovery and Development Process - researchgate.net
A biotech working on a new approach to IVF raises $33M in fresh funding - BioPharma Dive
New In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024 - Yahoo Finance
GenScript Biotech Corporation Announces Self-Amplifying RNA Synthesis Service for Advanced Therapeutic Applications - BioSpace
FDA defends lab test rule, as critics fear industry upheaval - BioPharma Dive
21 Atlanta Biotech Companies Making Waves in the Life Sciences Sector - Built In
ProteoMixture: A cell type deconvolution tool for bulk tissue proteomic data - ScienceDirect.com
Women’s health company Obseva to wind down, lay off staff - BioPharma Dive
Vitro Biopharma, Inc. Announces Chief Financial Officer Changes - MarketScreener
The TIM Company Appoints Biotech Veteran Dr. Behzad Mahdavi as Transformative CEO and Board Member - PR Newswire
Swiss investment firm denies acquisition bid for Boryung Biopharma - koreabiomed.com
Asep Medical Holdings Inc. Signs Joint Venture Agreement with Leading Chinese Medical Diagnostics Company Sansure Biotech Inc. - PR Newswire
UB-VV200 particles plus TumorTags control tumor growth in vivo - BioWorld MedTech
Navigate BioPharma Services, Inc. Announces Collaboration with BD (Becton, Dickinson and Company) to Advance Capabilities for Clinical Phases of Drug Development - PR Newswire
In Vitro Fertilization (IVF) Market Size & Share to Surpass $1296.47 Mn by 2030 | Vantage Market Research - Yahoo Finance
IPO Update: Vitro Biopharma Aims For $10 Million U.S. IPO (VTRO) - Seeking Alpha
Startup aims to make lab-grown human eggs, transforming options for creating families - NPR
VTRO IPO NewsStem cell biotech Vitro Biopharma sets terms for $10 million IPO - renaissancecapital.com
Global Stem Cells Market Research Report 2023: Implications - GlobeNewswire
Twist Bioscience Announces Robust Antibody Discovery Services Integrating In Vivo, In Vitro and In Silico Approaches - Business Wire
Vitro Biopharma, Inc. announced a financing transaction -January 05, 2023 - Marketscreener.com
STRO-003, novel ROR1-targeted ADC with potent activity in breast and lung cancer models - BioWorld MedTech
0.24%
3.39%
자본화:
|
볼륨(24시간):